Literature DB >> 12939300

Comprehensive evaluation of the extraocular muscle critical period by expression profiling in the dark-reared rat and monocularly deprived monkey.

Georgiana Cheng1, Michael J Mustari, Sangeeta Khanna, John D Porter.   

Abstract

PURPOSE: To address the consequences of visual deprivation paradigms in rat (dark rearing) and monkey (monocular deprivation) on extraocular muscle (EOM) development using genome-wide expression profiling.
METHODS: Serial analysis of gene expression (SAGE) was used to determine alterations in the EOM transcriptome induced by dark rearing of rats from birth to postnatal day 45. Data were compared with previously published normal EOM SAGE library. DNA microarray similarly assessed changes in gene expression patterns of EOMs of monkeys reared from birth to 4 months of age with monocular deprivation.
RESULTS: Dark rearing produced changes in expression of 280 transcripts in rat EOM. Of these, 71 were known genes representing functional categories that included energy metabolism/mitochondrial-related (21%), protein synthesis and modification (14%), lipid metabolism (13%), and muscle-related (6%) transcripts. Together, the predominant pattern reflected an energetic shift toward fatty acid beta-oxidation and integrated alterations in both myofibers and supportive tissues. The response of monkey rectus muscles to monocular deprivation was considerably less severe.
CONCLUSIONS: The visual deprivation paradigms used in this study mimic alterations that are associated with the common disorders of strabismus, congenital cataract, and amblyopia. These data show that postnatal EOM maturation is broadly susceptible to changes in activity patterns that are a consequence of visuomotor maldevelopment. The data extend the concept of an EOM-critical period and establish that activity patterns in developing eye movement systems play vital determinant roles in the novel EOM phenotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12939300     DOI: 10.1167/iovs.03-0170

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

Review 1.  Neural mechanisms of oculomotor abnormalities in the infantile strabismus syndrome.

Authors:  Mark M G Walton; Adam Pallus; Jérome Fleuriet; Michael J Mustari; Kristina Tarczy-Hornoch
Journal:  J Neurophysiol       Date:  2017-04-12       Impact factor: 2.714

2.  Correlation of cross-axis eye movements and motoneuron activity in non-human primates with "A" pattern strabismus.

Authors:  Vallabh E Das; Michael J Mustari
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

3.  Sustained release of bone morphogenetic protein-4 in adult rabbit extraocular muscle results in decreased force and muscle size: potential for strabismus treatment.

Authors:  Brian C Anderson; Mark L Daniel; Jeffrey D Kendall; Stephen P Christiansen; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-08       Impact factor: 4.799

4.  Functional magnetic resonance imaging of horizontal rectus muscles in esotropia.

Authors:  Kirsta Schoeff; Zia Chaudhuri; Joseph L Demer
Journal:  J AAPOS       Date:  2013-01-24       Impact factor: 1.220

5.  An altered phenotype in a conditional knockout of Pitx2 in extraocular muscle.

Authors:  Yuefang Zhou; Georgiana Cheng; Lisa Dieter; Tord A Hjalt; Francisco H Andrade; John S Stahl; Henry J Kaminski
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-30       Impact factor: 4.799

6.  Orienting auditory spatial attention engages frontal eye fields and medial occipital cortex in congenitally blind humans.

Authors:  Arun Garg; Daniel Schwartz; Alexander A Stevens
Journal:  Neuropsychologia       Date:  2007-02-25       Impact factor: 3.139

7.  Development of Machine Learning Models to Validate a Medication Regimen Complexity Scoring Tool for Critically Ill Patients.

Authors:  Mohammad A Al-Mamun; Todd Brothers; Andrea Sikora Newsome
Journal:  Ann Pharmacother       Date:  2020-09-15       Impact factor: 3.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.